Logo image of FLX

BINGEX LTD (FLX) Stock Fundamental Analysis

NASDAQ:FLX - Nasdaq - US0903371062 - ADR - Currency: USD

2.42  +0.05 (+2.33%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to FLX. FLX was compared to 22 industry peers in the Air Freight & Logistics industry. While FLX has a great health rating, there are worries on its profitability. FLX is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year FLX has reported negative net income.
FLX Yearly Net Income VS EBIT VS OCF VS FCFFLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -100M -200M -300M -400M

1.2 Ratios

FLX has a Return On Assets (-3.54%) which is in line with its industry peers.
FLX has a Return On Equity of -8.37%. This is comparable to the rest of the industry: FLX outperforms 54.55% of its industry peers.
With a Return On Invested Capital value of 1.81%, FLX perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
ROA -3.54%
ROE -8.37%
ROIC 1.81%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
FLX Yearly ROA, ROE, ROICFLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

With a Operating Margin value of 0.24%, FLX perfoms like the industry average, outperforming 40.91% of the companies in the same industry.
The Gross Margin of FLX (8.71%) is worse than 68.18% of its industry peers.
Industry RankSector Rank
OM 0.24%
PM (TTM) N/A
GM 8.71%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FLX Yearly Profit, Operating, Gross MarginsFLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 5 -5 -10

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FLX is destroying value.
FLX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FLX Yearly Shares OutstandingFLX Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 20M 40M 60M
FLX Yearly Total Debt VS Total AssetsFLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 200M 400M 600M 800M

2.2 Solvency

FLX has an Altman-Z score of 3.06. This indicates that FLX is financially healthy and has little risk of bankruptcy at the moment.
FLX has a Altman-Z score (3.06) which is comparable to the rest of the industry.
There is no outstanding debt for FLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.06
ROIC/WACC0.24
WACC7.54%
FLX Yearly LT Debt VS Equity VS FCFFLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 100M -100M 200M -200M 300M

2.3 Liquidity

A Current Ratio of 1.63 indicates that FLX should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.63, FLX is in the better half of the industry, outperforming 72.73% of the companies in the same industry.
FLX has a Quick Ratio of 1.63. This is a normal value and indicates that FLX is financially healthy and should not expect problems in meeting its short term obligations.
FLX has a better Quick ratio (1.63) than 77.27% of its industry peers.
Industry RankSector Rank
Current Ratio 1.63
Quick Ratio 1.63
FLX Yearly Current Assets VS Current LiabilitesFLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 200M 400M 600M 800M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 88.80% over the past year.
FLX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.14%.
EPS 1Y (TTM)88.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)13.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FLX Yearly Revenue VS EstimatesFLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 1B 2B 3B 4B

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FLX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FLX Price Earnings VS Forward Price EarningsFLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

FLX's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 19.38
FLX Per share dataFLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

FLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BINGEX LTD

NASDAQ:FLX (5/29/2025, 8:00:00 PM)

2.42

+0.05 (+2.33%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryAir Freight & Logistics
Earnings (Last)03-12 2025-03-12
Earnings (Next)N/A N/A
Inst Owners0.39%
Inst Owner Change-93.97%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap171.87M
AnalystsN/A
Price TargetN/A
Short Float %0.03%
Short Ratio0.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.27
P/FCF N/A
P/OCF N/A
P/B 2.89
P/tB 2.89
EV/EBITDA 19.38
EPS(TTM)-0.07
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS8.87
BVpS0.84
TBVpS0.84
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.54%
ROE -8.37%
ROCE 2.29%
ROIC 1.81%
ROICexc N/A
ROICexgc N/A
OM 0.24%
PM (TTM) N/A
GM 8.71%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover4.47
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.63
Quick Ratio 1.63
Altman-Z 3.06
F-ScoreN/A
WACC7.54%
ROIC/WACC0.24
Cap/Depr(3y)82.68%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.11%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)88.8%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)13.14%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y105.26%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y147.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y152.65%
OCF growth 3YN/A
OCF growth 5YN/A